Veliparib

TargetMol
Product Code: TAR-T2591
Supplier: TargetMol
CodeSizePrice
TAR-T2591-5mg5mg£112.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2591-1mL1 mL * 10 mM (in DMSO)£117.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2591-10mg10mg£130.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2591-25mg25mg£174.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2591-50mg50mg£245.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2591-100mg100mg£351.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2591-200mg200mg£527.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2591-500mg500mg£791.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Images

1 / 1

Further Information

Bioactivity:
Veliparib (ABT-888) is an orally bioavailable inhibitor of PARP (Kis: 5.2/2.9 nM for PARP1/2). It enhances apoptosis and autophagy.
CAS:
912444-00-9
Formula:
C13H16N4O
Molecular Weight:
244.298
Pathway:
DNA Damage/DNA Repair; Chromatin/Epigenetic; Autophagy
Purity:
0.9976
SMILES:
C[C@@]1(CCCN1)c1nc2c(cccc2[nH]1)C(N)=O
Target:
PARP; Autophagy

References

1. Donawho CK, et al. ABT-888, an orally active poly(ADP-ribose) polymerase inhibitor that potentiates DNA-damaging agents in preclinical tumor models. Clin Cancer Res. 2007 May 1;13(9):2728-37. 2. Liu F, et al. Effects of poly (ADP-ribose) polymerase-1 (PARP-1) inhibition on sulfur mustard-induced cutaneous injuries in vitro and in vivo. PeerJ. 2016 Apr 4;4:e1890. 3. Albert JM, et al. Inhibition of poly(ADP-ribose) polymerase enhances cell death and improves tumor growth delay in irradiated lung cancer models. Clin Cancer Res. 2007 May 15;13(10):3033-42. 4. Mao K, Chen J, Yu H, et al. Poly (ADP?ribose) polymerase 1 inhibition prevents neurodegeneration and promotes ??synuclein degradation via transcription factor EB?dependent autophagy in mutant ??synucleinA53T model of Parkinson's disease[J]. Aging Cell. 2020: e13163. 5. Epub 2020 May 31. PARP1 inhibition prevents neurodegeneration and promotes ?-synuclein degradation via TFEB-dependent autophagy in mutant ?-synucleinA53T model of Parkinson's disease. aging cell. 2020 Jun;19(6):e13163